Armstrong, A. J., Saad, F., Phung, D., Dmuchowski, C., Shore, N. D., Fizazi, K., . . . Bono, J. D. (2017). Clinical outcomes and survival surrogacy studies of prostate‐specific antigen declines following enzalutamide in men with metastatic castration‐resistant prostate cancer previously treated with docetaxel. Cancer.
Citação norma ChicagoArmstrong, Andrew J., et al. "Clinical Outcomes and Survival Surrogacy Studies of Prostate‐specific Antigen Declines Following Enzalutamide in Men With Metastatic Castration‐resistant Prostate Cancer Previously Treated With Docetaxel." Cancer 2017.
MLA引文Armstrong, Andrew J., et al. "Clinical Outcomes and Survival Surrogacy Studies of Prostate‐specific Antigen Declines Following Enzalutamide in Men With Metastatic Castration‐resistant Prostate Cancer Previously Treated With Docetaxel." Cancer 2017.